These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity. Cohen A; De Felice EA; Leb SM; Fuentes JG; Rothwell KG; Truant AP Curr Ther Res Clin Exp; 1968 Jul; 10(7):323-34. PubMed ID: 4969672 [No Abstract] [Full Text] [Related]
12. [Administration of fenfluramine in double blind trial in patients with exogenous obesity. Analysis of therapeutic results and effects on lipid metabolism]. Toledo SP; Neto GA Rev Bras Med; 1971 May; 28(5):240-5. PubMed ID: 4935137 [No Abstract] [Full Text] [Related]
13. Evaluation of three anorexiants. Clortermine hydrochloride (voranil), fenfluramine hydrochloride (pondimin), and mazindol (sanorex). Dykes MH JAMA; 1974 Oct; 230(2):270-2. PubMed ID: 4606535 [No Abstract] [Full Text] [Related]
14. The pharmacologic management of obesity. Cerda JJ J Fla Med Assoc; 1997 Feb; 84(2):89-92. PubMed ID: 9066231 [No Abstract] [Full Text] [Related]
16. Double-blind trial of anorectic agents. Sproule BC Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477 [No Abstract] [Full Text] [Related]
17. To the Editor: Fenfluramine (Poderax) for obesity. Jackson WP S Afr Med J; 1969 Sep; 43(39):1207. PubMed ID: 5353789 [No Abstract] [Full Text] [Related]
18. Fenfluramine in obesity. S Afr Med J; 1968 Jul; 42(27):682. PubMed ID: 5673819 [No Abstract] [Full Text] [Related]
19. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination. Weintraub M; Hasday JD; Mushlin AI; Lockwood DH Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610 [TBL] [Abstract][Full Text] [Related]